Tax group blasts Pfizer, urges stop to its tax-cutting deal

Tax group blasts Pfizer, urges stop to its tax-cutting deal


A consumer coalition is accusing drugmaker Pfizer of seeking to avoid $35 billion in U.S. taxes by buying fellow drugmaker Allergan, a deal structured to nominally move Pfizer's address to lower-tax Ireland, Allergan's home. In a report, Americans for Taxpayer Fairness says that would also slash New York-based Pfizer's future U.S. taxes.



from Biotech News